HOME >> BIOLOGY >> NEWS
Wake Forest Study: Dermatologists Provide Better, Cheaper Care For Fungal Skin Disease

WINSTON-SALEM, N.C.--Should you see a specialist for athlete's foot? You should if you want the infection cleared up faster and at less cost, according to researchers at the Wake Forest University School of Medicine.

Researchers at the school's Department of Dermatology found that family doctors, internists and other non-dermatologists were far more likely than dermatologists to prescribe less-effective yet more costly medications for athlete's foot and other fungal skin disease.

The study has implications not only for the public, but for health maintenance organizations that typically limit access to specialists in the belief that it reduces costs.

The results of the study, funded by Westwood-Squibb Pharmaceuticals, were published today (July 1) in the Journal of the American Academy of Dermatology.

Alan Fleischer, M.D., associate professor of dermatology, and others based their conclusion on an analysis of visits to doctors for fungal skin infections as recorded in the National Ambulatory Medical Care Survey for 1990-1994.

The survey recorded 4.1 million visits to doctors for fungal skin infections during those five years. Of those 4.1 million visits, 82 percent of the visits were to doctors other than dermatologists.

The data showed that 34.1 percent of the non-dermatologists prescribed drugs that combined cortisone with anti-fungal agents, compared with just 4.8 percent of the dermatologists.

This treatment is less effective than the single agents, such as Lotrimin (made by Schering Corp.), Nizoral (Janssen Pharmaceutica Inc), Lamisil (Sandoz Pharmaceuticals Corp.) and Exelderm (Westwood-Squibb), that the overwhelming number of dermatologists prescribed, Fleischer said.

"The cortisone keeps the anti-fungal drug from working as effectively," he said. "It doesn't completely cancel it out but it does, to some degree, cancel it out." Other studies have shown failure rates of
'"/>

Contact: Robert Conn or Jim Steele
RConn@WFUBMC.edu
336-716-4587
Wake Forest University Baptist Medical Center
1-Jul-1998


Page: 1 2 3

Related biology news :

1. Forest managers can fight invasive species that come with roads
2. Forest fire sensor inspired by nature
3. Rutgers ecologists and Brooklyn Botanic Garden botanists to plan Beijing Olympics Forest Park
4. Virginia Tech and North Carolina State University to run Forest Nutrition Research Cooperative
5. Forest preservation work turns to Carolina hemlock
6. Nonnative Invasive Plants of Southern Forests
7. Wake Forest researcher identifies syndrome as leading cause of death in premature infants
8. Wake Forest scientists develop colony of mice that fight off virulent cancer
9. Forest fragmentation may increase Lyme disease risk
10. USDA Forest Service publishes wildland-urban interface assessment
11. Forests of the continental U.S. continue to fragment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 25, 2020 , ... ... targeting mitochondria, in partnership with Essex Bio-Technology, a bio-pharmaceutical company specializing in ... 3 VISTA-2 study of SkQ1 ophthalmic solution in patients with moderate to ...
(Date:8/21/2020)... (PRWEB) , ... August 18, 2020 , ... ... to cell therapy, today announced that the U.S. Food and Drug Administration (FDA) ... Sentien’s lead asset, SBI-101, for the treatment of severe COVID-19. Approval of this ...
(Date:8/12/2020)... Mich. (PRWEB) , ... August 11, 2020 , ... ... R&D subsidiary based in Princeton, NJ, have entered into license agreements with Housey ... and development. Both Roche and J&J have annual Research and Development spending ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... Mass. and SOMERSET, N.J (PRWEB) , ... July ... ... leading genome editing company, and Catalent, the leading global provider of advanced delivery ... consumer health products, today announced that they have entered into a strategic partnership ...
(Date:7/18/2020)... ... 16, 2020 , ... After research model surgery and catheter implantation, the long ... only the beginning of a successful study, while protecting and accessing the catheter or ... Head of Surgery from Envigo in a live webinar on ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive license to ... move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. ...
(Date:7/1/2020)... ... 2020 , ... MedShift , a leading medical technology ... obstacles created as a result of COVID-19. As a provider at the forefront ... and medical manufacturers by expanding access to device offerings, technology services, and marketing ...
Breaking Biology Technology:
Cached News: